Card Player Poker Tour: Bicycle Main Event Begins October 10The Main Event Prize Pool is Estimated to be at Least $500,000 |
|
The race to a new winner from the Card Player Poker Tour Bicycle Casino series begins Oct. 10 at the famous Los Angeles-area casino.
The $1,100 no-limit hold’em main event features three days ones and uses the Bike’s own patented Quantum Reload concept. Tournament staff estimate the prize pool will be at least $500,000.
Players will have the option to buy-in directly for $1,100 on any of the three starting days, but those who wish to skip day 1 altogether can buy directly into day 2 for $4,300. Players that choose the latter option will begin with 60 big blinds with blinds at 1,000-2,000. There will be no-late entry on day 2, however players who are eliminated on any day 1 may re-enter the following day.
“The Quantum Reload concept is one tournament where you can come in different times, pay different amounts of money, and get different amounts of starting tournament chips,” said Tournament Director Mo Fathipour. “It’s the ability for the player to choose his or her day to play, depending on what day you choose dictates the amount of the buy-in and the amount of each starting stack. For the bigger tournaments, the players are coming on day two paying more money and starting with more chips.”
Each of the main event’s three starting days and day 2 will begin at 12 pm. The final day will begin at 2 pm and the final table will be streamed on Live at the Bike.
The CPPT has stopped at the Bicycle Casino two times in the tour’s history, crowning Thomas Beckstead and Shan Jing as main event champions. Beckstead left with $102,010 for his main event win, while Jing earned $135,981. Frank Ghezel left the 2014 CPPT series at the Bike as one of the biggest winners on the all-time CPPT money list. Ghezel won $192,202 after besting a field of 3,957 players in the $160 no-limit hold’em $1 million guarantee, placing him sixth on the tour’s all-time money list.
To see the complete structure of the main event, click here.